Related by context. All words. (Click for frequent words.) 68 trastuzumab DM1 T DM1 68 mertansine 67 telomerase therapeutic 67 telomerase inhibitor drug 66 oral prodrug 66 PEG SN# 66 Marqibo TM 65 Enzastaurin 65 ENMD # 65 Tesetaxel 65 aurora kinase 65 Tß4 65 GRNVAC1 64 thalidomide Thalomid 64 fosbretabulin 64 radiotherapeutic 64 preclinical efficacy 64 Fludara ® 64 Squalamine 64 Solazed TM 64 ocular formulation 64 Lenocta 63 PI3K/Akt pathway inhibitor 63 multitargeted 63 epoetin alpha 63 Zemiva TM 63 IL# PE#QQR 63 PSMA ADC 63 vaccine GRNVAC1 63 Azedra ™ 63 antisense inhibitors 63 Cardiotoxicity 63 HDAC Inhibitor 63 novel peptide 63 GRN#L 63 PDX pralatrexate 63 NEUGENE 63 Factor VIIa 63 TELINTRA 63 paclitaxel Taxol ® 63 Androxal TM 63 CD# CEA 62 SPRYCEL ® 62 docetaxel Taxotere ® 62 squalamine 62 YONDELIS 62 sodium thiosulfate STS 62 Azedra 62 TÎ ² 4 62 darinaparsin ZIO 62 azacytidine 62 EGFR HER2 62 investigational humanized monoclonal antibody 62 GLP toxicology studies 62 Neupogen ® 62 immune modulating 62 Orally administered 62 MCSP respectively 62 GW# [003] 62 HQK 62 INS# [001] 62 interferon IFN 62 Aplidin 62 TRX1 62 Reports Preclinical Data 62 Onconase 61 CYT# potent vascular disrupting 61 Aplidin R 61 intradermal injections 61 INCB# [001] 61 candidate CRLX# 61 verteporfin 61 RNA antagonist 61 Carfilzomib 61 metastatic neuroendocrine tumors 61 histone deacetylase HDAC inhibitor 61 immuno modulatory 61 prokinetic agent 61 BrachySil TM 61 antitumoral 61 oncolytic virus therapies 61 Dalbavancin 61 hA# 61 PEGylated interferon 61 depsipeptide 61 receptor tyrosine kinase inhibitor 61 rxRNA 61 histone deacetylase HDAC 61 Archexin 61 proteasome inhibitor 61 pan HDAC inhibitor 61 antiangiogenesis 61 DUROS 61 IMiDs R 61 BiovaxID TM 61 vinca alkaloid 61 histone deacetylase inhibitor 61 neratinib 61 huC# DM4 61 Presents Preclinical Data 61 Darinaparsin 61 CRLX# 61 antitumor effects 61 alemtuzumab MS 61 non nucleoside HCV 61 novel histone deacetylase 61 PDE4 inhibitor 61 microtubule inhibitor 61 Phase IIb clinical trials 60 flavopiridol 60 liposomal formulation 60 tubulin inhibitor 60 MAGE A3 ASCI 60 XL# XL# 60 OMP #M# 60 G#DT 60 Cethrin R 60 teriflunomide 60 vivo potency 60 trastuzumab emtansine T DM1 60 potently inhibit 60 preclinically 60 SinuNase TM 60 Tigecycline 60 Xanafide 60 cMET 60 favorable pharmacokinetic profile 60 gefitinib Iressa 60 generation purine nucleoside 60 antineoplastic 60 Anti angiogenic 60 LEP ETU 60 antisense inhibitor 60 chimeric monoclonal antibody 60 BiTE R 60 PrevOnco ™ 60 Immunotherapeutic 60 peptide conjugated 60 Romiplostim 60 Immunomodulatory 60 Azedra TM Onalta TM 60 Thalomid ® 60 Cotara ® 60 alvespimycin 60 Enzyme Replacement Therapy 60 Novel Oral 60 trastuzumab Herceptin ® 60 vascular disrupting agents 60 kidney urologic 60 Antiviral Activity 60 hypereosinophilic syndrome 60 JAK inhibitors 60 Anticalin ® 60 synDNA TM 60 targeted radiotherapeutic 60 DiLA2 60 JAK2 inhibitor 60 MGd 60 lintuzumab SGN 60 IMiDs ® 60 forodesine 60 Deforolimus 60 systemically administered 60 Aganocide ® 60 Tumor Necrosis Factor 60 potent cytotoxic 60 IMiDs ® compound 60 bortezomib Velcade 60 SYN# 60 ON #.Na 60 MKC# MT 60 TLR9 agonists 60 Curaxin CBLC# 60 Prolongs Survival 60 alkylating agent 60 FOLOTYN ® 60 antimitotic 60 nucleoside analog 60 Sym# 60 vivo preclinical 60 solithromycin 60 Pertuzumab 59 nucleoside analogs 59 vitro cytotoxicity 59 sipuleucel T 59 immunoconjugate 59 HepDirect prodrug 59 LNP formulations 59 CEQ# 59 targeted antifolate 59 Omacetaxine 59 novel anticancer 59 targeted nucleotide prodrug 59 synthetic retinoid 59 Cytotoxic 59 telomerase inhibitor 59 taxane resistant 59 AKT inhibitor 59 IgG1 monoclonal antibody 59 potently inhibited 59 selective modulator 59 XL# inhibits 59 Recombinant Human 59 CTAP# Capsules 59 MOZOBIL 59 inhibitor RG# 59 protein kinase inhibitors 59 LEUKINE 59 Assay Kits 59 Monoclonal 59 adenoviral 59 Rigel R# 59 samarium Sm 59 anti CD# antibodies 59 HDACi 59 phase IIb trial 59 humanized monoclonal 59 Hsp# Inhibitor 59 polycythemia vera PV 59 Phase Ib clinical 59 JAK inhibitor 59 Genasense ® oblimersen 59 Neulasta R 59 hormone agonist 59 Preclinical Data 59 monoclonal antibody mAb 59 isoform selective 59 Cloretazine 59 ESBA# 59 Vaxfectin TM 59 GMX# 59 CCR1 59 CD# antibody [001] 59 Systemic Delivery 59 Janus Kinase 59 peptibody 59 Allogeneic 59 radiolabeled 59 orally dosed 59 PORxin TM platforms 59 acyclovir Lauriad R 59 p# biomarker 59 intranasal formulation 59 lexidronam injection 59 immunoregulation 59 topoisomerase II inhibitor 59 combinability 59 efaproxiral 59 TLK# 59 Kit CD# positive 59 immunotherapeutic agent 59 Solazed 59 TRAIL receptor antibodies 59 gastrointestinal stromal tumors GISTs 59 xenograft models 59 potent anticancer 59 SERMs 59 candidates Azedra TM 59 pharmacodynamic markers 59 PEGPH# 59 preclinical pharmacokinetic 59 Epidermal Growth Factor Receptor 59 Initiate Clinical Trial 59 MorphoSys proprietary 59 TLR antagonists 59 cancer immunotherapies 59 PROSTASCINT R 59 alpha interferons 59 Clusterin 59 NMDA antagonists 59 siRNA duplexes 59 ALN PCS 59 anti angiogenic agent 59 HDL Mimetic Peptide 58 Chemokine Receptor 58 R sorafenib tablets 58 mda 7 58 Lymphoid 58 cilengitide 58 radezolid 58 Trofex 58 tubulin binding 58 selective inhibition 58 RGB # 58 HGS ETR2 58 MEK inhibitors 58 ALN TTR# 58 Granulocyte Colony Stimulating Factor 58 urocortin 2 58 Taxotere chemotherapy 58 Azacitidine 58 Temsirolimus 58 GHRH 58 microtubule targeting 58 Anticalins R 58 Zenvia Phase III 58 BAL# [002] 58 potent antiproliferative 58 Kinase Inhibitor 58 Prodarsan R 58 BNC# 58 selective adenosine 58 vidofludimus 58 TPI ASM8 58 delipidation 58 VEGF inhibitors 58 Myolimus 58 Blinatumomab 58 PhG alpha 1 58 JAK1 58 pharmacodynamic PD 58 IAP inhibitors 58 mTOR inhibitors 58 Glybera 58 TNF alpha antagonist 58 VNP#M 58 polyclonal 58 REMINYL ® 58 ALN TTR 58 AMPK activators 58 Tyrosine Kinase Inhibitor 58 antifolates 58 Pharmacodynamic 58 busulfan 58 antisense oligonucleotides 58 Personalized Immunotherapy 58 erythropoietic 58 Vidaza R 58 peripheral blood mononuclear 58 Therapeutic Vaccine 58 docetaxel Taxotere R 58 replicon 58 Luteinizing Hormone Releasing Hormone 58 BENLYSTA ® 58 Vidaza azacitidine 58 bevacizumab Avastin ® 58 DURIN TM 58 peptidomimetic 58 NS#/#A protease 58 NOD SCID mice 58 QUADRAMET R 58 #D#C# 58 mTOR mammalian target 58 Locked Nucleic Acid LNA 58 Cintredekin Besudotox 58 investigational monoclonal antibody 58 Initiates Enrollment 58 allergic airway inflammation 58 nucleotide analog 58 cysteamine bitartrate 58 mGluR2 NAM 58 Panzem 58 recombinant antibodies 58 ritonavir boosted 58 multicenter Phase II 58 Akt inhibitor 58 selective kinase inhibitor 58 THR beta agonist 58 ArQule Kinase Inhibitor Platform 58 Yondelis ® 58 genitourinary cancers 58 immune modulatory 58 amikacin 58 Initiates Clinical Trial 58 dasatinib Sprycel 58 liposome formulation 58 Pathway Inhibitor 58 Interferon alpha 58 Initiates Clinical 58 HCV protease inhibitors 58 receptor inhibitor 58 vivo validation 58 REGN# 58 PI3K Akt 58 CCX# 58 Fc fusion protein 58 erythropoiesis 58 gastrointestinal motility disorders 58 Factor Receptor 58 Glycosylation 58 refractory chronic lymphocytic 58 A3 adenosine receptor 58 PI3K/mTOR 58 JAK Inhibitor 58 HCV polymerase 58 delafloxacin 58 butyrylcholinesterase 58 Achieves Primary Endpoint 58 Myocet 58 Glatiramer acetate 58 Interferon Beta 58 bioscavenger 58 GAP #B# 57 myeloproliferative disorders 57 humanized anti 57 JAK2 inhibitors 57 Onalta ™ 57 Safinamide 57 Fibroblast Growth Factor Receptor 57 TAKSTA 57 DNA intercalator 57 peptide antigens 57 phase IIb clinical 57 cytotoxicity assays 57 Glypromate 57 murine models 57 oral JAK1 57 PARP Inhibitor 57 Morpholino 57 GRNCM1 57 Aurora Kinase 57 benzimidazole 57 humanized antibody 57 XTEN 57 antimetabolites 57 UPLYSO 57 Dacogen decitabine 57 Panzem ® 57 Ecallantide 57 HGS# 57 paclitaxel Taxol 57 Curaxin 57 monoclonal antibody MAb 57 novel emulsion formulation 57 IFN α 57 PORxin TM 57 mimetic compounds 57 Aurexis R 57 Gleevec imatinib mesylate 57 NeoLipid TM 57 HuCAL R 57 wilate ® 57 Ultrafast Insulin 57 potent suppressor 57 RECOTHROM R 57 Amrubicin 57 immunomodulatory agents 57 hyaluronidase enzyme 57 Fulvestrant 57 potent antitumor 57 Symadex 57 Vitaxin 57 Biolimus A9 57 Nexavar sorafenib 57 antisense compounds 57 Cimzia ® certolizumab pegol 57 antibody MAb 57 TG# [003] 57 poly ethylene glycol PEG 57 haematologic malignancies 57 radiolabeled monoclonal antibody 57 AT1R 57 Xcytrin R 57 plasmid DNA vaccine 57 inhibits VEGF 57 myeloproliferative diseases 57 NEUGENE R 57 Present Preclinical Data 57 Liprotamase 57 DAS# Fludase ® 57 biologic therapeutics 57 Chronic Lymphocytic Leukemia CLL 57 Tumor Response 57 Alfacell proprietary ribonuclease 57 NSCLC tumors 57 PBMCs 57 intravesical instillation 57 UsiRNAs 57 OvaRex MAb 57 pegylated recombinant 57 Optiquel ™ 57 InterfeRx 57 Diabetic Neuropathy 57 Anticalins ® 57 HuMax 57 Anti Tumor 57 PPARgamma 57 P#X# antagonist 57 Aptamer 57 Estrogen Receptor 57 pegylated 57 ADP receptor antagonist 57 Allovectin 7 r 57 Aganocide 57 lumiliximab 57 small molecule activator 57 malignant ascites 57 Cytochrome P# 57 Demonstrates Efficacy 57 investigational compounds 57 antiproliferative 57 HuMax TAC 57 BiTE 57 hPTH #-# 57 DermaVir 57 polymerase inhibitors 57 Collategene 57 molecular biomarkers 57 AdnaTest 57 liposomal formulations 57 PI3K inhibitor 57 effector function 57 intradermal injection 57 p# inhibitor 57 CINTREDEKIN BESUDOTOX 57 Soliris eculizumab 57 antifibrotic 57 TLR9 agonist 57 lipopeptide 57 anti CD3 57 MYLOTARG 57 ART# 57 mediated inhibition 57 immunological diseases 57 TKM ApoB 57 FK# 57 anti secretory 57 highly selective inhibitor 57 Lpathomab 57 OXi# 57 Dasatinib 57 INxin TM 57 resolvins 56 small molecule tyrosine 56 pDNA vaccine 56 acetonide FA 56 adipogenic 56 PDE# inhibitors 56 PKC# 56 familial amyloidotic polyneuropathy FAP 56 pertuzumab 56 Preclinical studies suggest 56 Actimmune ® 56 Solorel TM 56 Revimmune TM 56 tafamidis 56 anticancer compound 56 anti neoplastic 56 gamma secretase inhibitor 56 Completes Patient Enrollment 56 Zalypsis 56 HepDirect 56 haematological malignancies 56 RNAi Therapeutic 56 Beta catenin pathway 56 Raptiva R 56 TRAIL receptors 56 assay detects 56 DOS# 56 Cyclosporin 56 osteogenic 56 Adnectin 56 Antiangiogenic 56 Vectibix panitumumab 56 epigenetic therapies 56 personalized immunotherapy 56 Announces Poster Presentations 56 selective antagonist 56 Tr DNA 56 Cyclosert 56 cytoprotective 56 Anti Phospholipid Therapy 56 humanized monoclonal antibodies 56 JZP 56 personalized dendritic 56 Novasome R 56 HuCAL GOLD R 56 antiapoptotic 56 NP2 Enkephalin 56 direct thrombin inhibitors 56 recombinant factor VIIa 56 Liposomal 56 factor G CSF 56 miRview meso 56 FGFR 56 pentostatin 56 Canvaxin TM 56 thrombin receptor 56 mouse xenograft models 56 affinity ligands 56 dextromethorphan quinidine 56 HSP# inhibitor 56 indibulin 56 proteasome inhibitors 56 interleukin IL -# 56 Protease Inhibitor 56 HGS ETR1 mapatumumab 56 prostone 56 LPM TM 56 Receives Orphan Drug Designation 56 Th2 cytokines 56 iron dextran 56 immunomodulatory 56 Interferon Alpha 56 targeting CD# 56 vascular disrupting 56 tumorigenicity 56 Kahalalide F 56 selective agonists 56 ALK inhibitors 56 Hsp# inhibitors 56 Alocrest 56 pharmacokinetic PK profile 56 recombinant adeno associated 56 adenovector 56 GSK3B 56 cleavable linker 56 molecular diagnostic assay 56 radiolabeled TM# 56 factor receptor FGFR 56 IgM antibody 56 Oncolytic 56 kallikrein 56 Tarvacin Anti Viral 56 novel immunotherapeutic 56 chronic eosinophilic leukemia 56 humanized antibodies 56 Bruton tyrosine kinase Btk 56 AQ4N 56 PEGylated Fab fragment 56 p# inhibitors 56 Campath alemtuzumab 56 Introgen ADVEXIN 56 non nucleoside 56 volociximab 56 CDK inhibitor 56 RNAi therapeutic targeting 56 Nexavar sorafenib tablets 56 orally bioavailable mimics 56 MyVax R 56 Anidulafungin 56 BiTE Antibody 56 FLT3 56 G Protein Coupled 56 Alequel 56 SABCS 56 AIR# [001] 56 neurotrophic 56 fluconazole resistant 56 ruxolitinib 56 prolyl hydroxylase inhibitors 56 subunit vaccines 56 Parathyroid Hormone 56 novel immunomodulatory 56 Plicera 56 beta interferons 56 NS5A 56 Tesmilifene 56 See CLINICAL PHARMACOLOGY 56 lymphoid tumors 56 PathHunter 56 liposome injection 56 polyclonal antibody 56 Histone Deacetylase 56 immunotoxins 56 tolerogenic 56 Hepatocytes 56 Degarelix 56 tyrosine kinase inhibitor 56 anti infective treatments 56 Thiovir 56 mitogen activated ERK kinase 56 Tarvacin TM 56 REMUNE R 56 Alequel ™ 56 acadesine 56 histone deacetylase HDAC inhibitors 56 dotLab System 56 Placebo Controlled Trial 56 Regenerative Cells 56 Maribavir 56 YONDELIS R 56 Tarvacin 56 Arcelis ™ 56 Flt3 56 HIV integrase inhibitors 56 Kinase Inhibitors 56 HER2 ErbB2 56 intratumoral injection 56 pediatric acute lymphoblastic 56 HuMax CD4 56 Pimavanserin 56 Decitabine 56 PEGylated anti 56 sunitinib Sutent 56 FVIIa 56 adipiplon 56 antiproliferative effects 56 deCODE chemistry 56 phase III isavuconazole 56 Pharmacodynamics 56 ZFP Therapeutic TM 56 Bosutinib 56 ISTODAX 56 VDAs 56 nucleoside analogues 56 Vidaza ® 56 cynomolgus monkeys 56 HCV replicon 56 therapeutic monoclonal antibody 56 Lixivaptan 56 IL# PE 56 Interferon Gamma 56 aminolevulinic acid 56 mRNA antagonists 56 oral salmon calcitonin 56 Microplasmin 56 thiazolides 56 uricase 56 reslizumab 56 ZFP TFs 56 Gleevec resistant 55 immune modulator 55 IMiDs 55 Pegylated Interferon 55 Etravirine 55 peptides proteins 55 candidate TNFerade biologic 55 protein tyrosine phosphatase 1B 55 monoclonal 55 protein tyrosine phosphatase 55 renoprotective 55 Anavex #-# 55 CLL SLL 55 antitumour 55 Monoclonal Antibody 55 TOCOSOL 55 Ataluren 55 Alkaline Phosphatase 55 lapatinib Tykerb 55 Spiegelmer ® 55 oral antiviral 55 biodegradable implant 55 MOVIPREP R 55 Radezolid 55 fluocinolone acetonide 55 immatics 55 ALK inhibitor 55 anionic backbone 55 GeneICE 55 mAbs 55 Hedgehog pathway inhibitor 55 Clinical Trial Data 55 JVRS 55 Psoraxine R 55 histologies 55 Sanvar R 55 Progenitor Cells 55 GPx 55 Valopicitabine 55 Zenvia ™ 55 Posiphen TM 55 cyclophilin inhibitor 55 LAB CGRP 55 Epothilone 55 cationic lipid 55 cellular immunotherapy 55 HepeX B 55 HuLuc# 55 Inhalation Solution 55 PEGylated 55 trastuzumab Herceptin R 55 virus AAV 55 Thrombin 55 Denufosol 55 idiopathic thrombocytopenic purpura ITP 55 intranasal delivery 55 anti CD3 antibody 55 enzyme inhibitors 55 Phase 2a Trial 55 maturation inhibitor 55 imatinib Gleevec 55 antiepileptics 55 Stapled Peptide 55 Mesenchymal 55 Selective Electrochemical Tumor Ablation 55 monoclonal anti 55 cidofovir 55 HCV polymerase inhibitor 55 PARI Pharma GmbH 55 CDDO Im 55 interferon gamma 1b 55 EP #R 55 darunavir Prezista 55 lymphoid malignancies 55 immunomodulator 55 MT#/MEDI-# 55 preclinical pharmacology 55 Oncophage vitespen 55 milatuzumab 55 flow cytometric 55 PNT# 55 abacavir Ziagen 55 MEK inhibitor 55 renin inhibitors 55 SNALP 55 cytotoxic effects 55 M2 subunit 55 Receptor Antagonists 55 Lauriad R 55 Civacir 55 prostanoid 55 R roscovitine 55 OHR/AVR# 55 P#X# 55 tranilast 55 Myeloperoxidase 55 antiangiogenic drugs 55 AMD# [003] 55 hERG 55 infused intravenously 55 THALOMID 55 inhibit angiogenesis 55 lentiviral 55 menadione 55 ISF# 55 immunotoxin 55 HSP# inhibitors 55 Tyrima 55 anticoagulant reversing agent 55 BAL# [001] 55 bortezomib Velcade ® 55 bispecific 55 novel vascular disrupting 55 filgrastim 55 biomarker assay 55 lymphoma subtypes 55 LEAPS TM 55 NABTT 55 MTP inhibitor 55 cisplatin resistant 55 Phase Ib Clinical Trial 55 romazarit 55 IL 1ß 55 annexin 55 transgenic rats 55 small molecule defensin 55 rBChE 55 Initiates Phase II 55 inhibitor PPI 55 Altastaph 55 rifamycins 55 Protein Expression 55 Plasmid DNA 55 PET tracers 55 ZFP TF 55 Neugene 55 Theratope 55 enzyme inhibitor 55 2 methoxyestradiol 55 Leukine ® 55 #th Interscience Conference 55 NEUGENE antisense 55 APiX 55 Small Molecule 55 vitamin D analogs 55 TransVax tm 55 hematologic disorders 55 siRNAs targeting 55 Fabry Disease 55 gastric adenocarcinoma 55 liposomal 55 Cellcept 55 OncoGel 55 HCV Genotype 55 Seliciclib 55 Friedreich Ataxia FRDA 55 EGS# 55 proteasome inhibition 55 HCV protease 55 Myelodysplastic syndromes MDS 55 tumor specific antigen 55 EVIZON TM 55 Vaxfectin R 55 intravenous AAT 55 thrombolytic agent 55 Survivin antagonist 55 SuperAntibody 55 Preclinical Study 55 MCF7 54 PEG IFN 54 treat chronic sinusitis 54 Transdermal Delivery 54 synthetic siRNA 54 Mutational 54 GelSite polymer 54 Presents Preclinical 54 Parathyroid hormone 54 transient transfection 54 PD LID 54 Protease Inhibitors 54 albumin bound paclitaxel 54 Prodrug 54 parasitemia 54 potentially hepatotoxic 54 acyclovir Lauriad ® 54 AEG# 54 Renal Cell Cancer 54 potent inhibitors 54 AtuRNAi 54 EV# vaccine 54 topically administered 54 Polymerase Inhibitor 54 5 HT2C 54 BRAF inhibitors 54 pan genotypic 54 cutaneous T 54 viral kinetics 54 AZX# 54 Vaprisol 54 CDK inhibitors 54 isotypes 54 sargramostim 54 neuronal nicotinic receptor NNR 54 NXL# 54 calcineurin inhibitor 54 Sipuleucel T 54 radionuclide therapy 54 hyperphenylalaninemia HPA due 54 Solid Tumors 54 Oligonucleotide 54 trodusquemine 54 HBV replication 54 lipid nanoparticle LNP 54 pDNA vaccines 54 Liprostin 54 JAK3 inhibitor 54 Smac mimetics 54 anti androgens 54 Corgentin 54 CCR5 antagonist 54 PLA2 54 Hormone Refractory Prostate Cancer 54 NEUMUNE 54 polysaccharide polymer 54 ALN HTT 54 NAGS deficiency 54 lipid nanoparticle 54 leukemia AML 54 #ME# 54 Nilotinib 54 AZILECT ® 54 orally bioavailable 54 Phase III randomized controlled 54 targets Galectin receptors 54 liposomal delivery 54 ICAAC IDSA 54 PI3 kinase inhibitors 54 topical gel containing 54 glucokinase activator 54 inhaled AAT 54 doxercalciferol 54 antidiabetic 54 immunomodulatory properties 54 immuno therapeutic 54 proteins peptides 54 serine protease 54 ARIKACE ™ 54 DXL TM 54 sodium Injection 54 SIRT2 54 rxRNA ™ compounds 54 bifunctional 54 Macrophage 54 NTDDS 54 AeroLEF R 54 mitotic kinesins 54 Begins Dosing 54 CB1 antagonists 54 capsular polysaccharide 54 virosome technology 54 PLAVIX ® 54 AASLD Meeting 54 HYLENEX recombinant 54 Enhanze Technology 54 NN# [001] 54 Campath ® 54 Peginterferon alfa 2b 54 irreversible inhibitor 54 oncologic diseases 54 MAb 54 Mutation Analysis 54 hepatoma 54 ResponseDX Lung TM 54 Monoclonal antibody 54 bispecific antibody 54 DermaVir Patch 54 RNA antagonists 54 JAK2 enzyme 54 adenosine A2A 54 NeuroVax TM 54 topical formulations 54 Immunosuppression 54 rhIGF-I/rhIGFBP-3 54 phosphoprotein 54 Regimens 54 HTS assay 54 Technosphere ® 54 Radilex